Medtronic is sponsoring a quality improvement study called Brady MX. It is hypothesized that lack of awareness of treatment and diagnostics pathways result in lower number of referrals to implanters of IPG.
Study Type
OBSERVATIONAL
Enrollment
113
Patient might require IPG device to be implanted under standard of care
Hospital General de Tijuana
Tijuana, Estado de Baja California, Mexico
Hospital General de Cancun
Cancún, Quintana Roo, Mexico
Hospital General del Estado de Sonora
Hermosillo, Sonora, Mexico
Hospital Regional Universitario de Colima
Colima, Mexico
Absolute Change in the Proportion of Subjects Diagnosed With SND at Pre Specific Time.
Because the study intervention was not conducted, it is not possible to compare the proportion of subjects with an SND diagnosis pre-intervention (Phase I) to the proportion post-intervention (Phase II). Instead, the proportion of subjects with an SND diagnosis in Phase I are reported
Time frame: 6 and 12 months
Number of SND Subjects Receiving a Referral for an Indicated IPG Device After the Intervention
The change between subjects referred to an indicated IPG will be measured after the intervention in total number of patients that are referred correctly. Because the study intervention was not conducted, it is not possible to compare the proportion of subjects receiving therapy referral for an indicated IPG pre-intervention (Phase I) to the proportion post-intervention (Phase II). Instead, the proportion of SND subjects receiving a referral for an indicated IPG device in Phase I are reported.
Time frame: 3, 6, and 15 months
This platform is for informational purposes only and does not constitute medical advice. Always consult a qualified healthcare professional.
Hospital General de Queretaro
Querétaro, Mexico